Pricing Log in Create free account

Avalo Therapeutics, Inc. (AVTX) vs Editas Medicine, Inc. (EDIT)

Avalo Therapeutics, Inc. and Editas Medicine, Inc. are both Biotechnology companies. Avalo Therapeutics, Inc. and Editas Medicine, Inc. are of similar size ($399.3M and $388.8M). Editas Medicine, Inc. grew revenue faster over the last twelve months: 20.8% against −92.7%. Avalo Therapeutics, Inc. has the higher net margin (0.00% vs −157.3%) and the lower return on invested capital (−118.2% vs 0.00%). Across the 17 metrics below, Avalo Therapeutics, Inc. leads on 9 and Editas Medicine, Inc. on 8.

Valuation

Metric AVTX EDIT Biotechnology median
P/E n/m n/m 10.64
P/S 254.55 6.60 9.59
P/B 0.71 2.95 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA 0.78 n/m 0.65
EV/Sales (57.24) 2.79 9.45
Earnings yield (65.26%) (28.85%) (34.69%)
Free cash flow yield (43.84%) (38.78%) (24.02%)

Profitability

Metric AVTX EDIT Biotechnology median
Gross margin 64.72% 100.00% 65.59%
Operating margin 0.00% (161.39%) 0.00%
Net margin 0.00% (157.32%) 0.00%
Free cash flow margin 0.00% (255.88%) 0.00%
Return on equity (36.27%) (118.82%) (51.96%)
Return on assets (32.50%) (33.02%) (46.06%)
Return on invested capital (118.21%) 0.00% 0.00%

Growth

Metric AVTX EDIT Biotechnology median
Revenue growth (TTM) (92.65%) 20.83% 4.59%
EPS growth (last fiscal year) 72.07% 37.50% 29.88%
Revenue growth, 5-year CAGR (61.19%) (14.89%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVTX EDIT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 19.31 3.19 4.86
Net debt to EBITDA 1.36 0.94 1.01

Dividend

Metric AVTX EDIT Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric AVTX EDIT Biotechnology median
Market cap 388.82m 399.31m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack